VHL 7.69% 14.0¢ virax holdings limited

Previous trials with TCN-P

  1. 5,583 Posts.
    lightbulb Created with Sketch. 1
    Tested, Trialled and Dusted some 40 years ago. The general conclusion was: "We conclude that triciribine is ineffective at all doses tested and at doses of ≥35 mg/m2 has unacceptable toxic effects." [Hoffman et al. Cancer Chemotherapy and Pharmacology, 1996, 37:3, pp 254-258. Buyer Beware.

    http://www.ncbi.nlm.nih.gov/pubmed/...he Cervix: A Gynecologic Oncology Group Study

    http://www.ncbi.nlm.nih.gov/pubmed/...cancer. Cancer Treat Rep 71(3): 333-334, 1987

    http://www.ncbi.nlm.nih.gov/pubmed/8256767

    http://www.ncbi.nlm.nih.gov/pubmed/...oside phosphate) for metastatic breast cancer

    http://www.ncbi.nlm.nih.gov/pubmed/...using a five-day continuous infusion schedule

    http://www.ncbi.nlm.nih.gov/pubmed/6825123
 
watchlist Created with Sketch. Add VHL (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.